| ★ | BE HEARD EXT: Bimekizumab Shows Greater Benefit With Earlier Use in HS | | 14 | Estados Unidos | |
| 20 | Chemicals Sector At Risk? Vijay Shankar Flags Cost Risks,Competitiveness Challenges | ET Now #shorts | | — | India | 60 |
| 9 | Understanding VO2 Max: Why Exercise Matters for Heart Health and Longevity | Stanford Health Care @stanfordhospital | 45.3K | Estados Unidos | 62 |
| 19 | MUKESH BARNWAL | All India Rank-465 | IAS/UPSC Topper | IAS/UPSC Result 2025-26 | AIR-465 UPSC/CSE | Chahal Academy @chahalacademy | 1.1K | India | 60 |
| 16 | ROHIT GARG | All India Rank-470 | IAS/UPSC Topper | IAS/UPSC Result 2025-26 | AIR-470 UPSC/CSE | Chahal Academy @chahalacademy | 260 | India | 60 |
| 6 | Hair Loss Update 2026: JAK Inhibitors, Oral Minoxidil, and Sequencing | | 209 | Estados Unidos | 64 |
| 12 | What Comes Next for PORT-77 as It Heads Toward Phase 2b/3? | | 196 | Estados Unidos | 61 |
| 2 | Guideline-Directed Care Improves Limb Outcomes in Peripheral Artery Disease | | 109 | Estados Unidos | 68 |
| 8 | Survey Shows Peptide Misinformation, Misuse Rising in US | | 108 | Estados Unidos | 62 |
| 14 | Phase 3b Data on Ixekizumab, Tirzepatide for Psoriasis and Overweight, With Mark Lebwohl, MD | | 88 | Estados Unidos | 61 |
| 17 | SYMPHONY-PE: Early Thrombectomy Improves Pulmonary Embolism Outcomes | | 86 | Estados Unidos | 60 |
| 1 | Bimekizumab Data Support Case for Earlier Intervention in HS | | 78 | Estados Unidos | 74 |
| 11 | How to Sequence Omalizumab, Dupilumab, and Remibrutinib in CSU | | 74 | Estados Unidos | 61 |
| 5 | Spotting Scarring Alopecia Before It's Too Late | | 42 | Estados Unidos | 65 |
| 15 | What is the Link Between Atopic Dermatitis and Asthma? With Eingun James Song, MD | | 40 | Estados Unidos | 60 |
| 3 | Increasing Guideline-Directed Care Adherence in Peripheral Artery Disease | | 31 | Estados Unidos | 68 |
| 18 | Addressing the Manifold Barriers in Hypertension, With Michael Miedema, MD | | 27 | Estados Unidos | 60 |
| 10 | IBS-C Treatment Cycling Linked to Higher Healthcare Utilization | | 23 | Estados Unidos | 61 |
| 13 | Plutomen to exhibit @GitexTechWeek | Meet our representative at Dubai. | | 20 | — | 61 |
| 7 | Time to Minimum Residual C-Peptide As a Predictor of Treatment Efficacy in T1D | | 16 | Estados Unidos | 62 |
| 4 | The Cost of Delay: How Prior Authorization Is Impacting Dermatology | | 12 | Estados Unidos | 66 |